Clinical Trials Directory

Trials / Completed

CompletedNCT04809246

Prisons Evaluation of a One-stop-shop InterVentiOn

Prisons Evaluation of a One-stop-shop InterVentiOn to Scale-up Hepatitis C Testing and Treatment (PIVOT)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
541 (actual)
Sponsor
Kirby Institute · Other Government
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

A prospective historically controlled study to assess the effect of an intervention integrating point-of-care hepatitis C (HCV) RNA testing, non-invasive liver fibrosis assessment, fast-tracked direct-acting antiviral (DAA) prescription, and linkage to hepatitis care (a 'one-stop-shop' intervention), on the proportion of participants initiating DAA therapy among people who are recently incarcerated within reception correctional centre(s) in Australia.

Conditions

Interventions

TypeNameDescription
OTHER'One-stop-shop' hepatitis clinicEstablishment of a 'one-stop-shop' hepatitis clinic, integrating point-of-care HCV RNA testing, followed by clinical assessment, non-invasive liver fibrosis assessment by fibro-elastography (Fibroscan), and early DAA prescription (for those with chronic HCV) followed by linkage to ongoing hepatitis care, all in the same 60-minute visit.

Timeline

Start date
2019-10-31
Primary completion
2021-04-23
Completion
2021-09-10
First posted
2021-03-22
Last updated
2022-01-14

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT04809246. Inclusion in this directory is not an endorsement.

Prisons Evaluation of a One-stop-shop InterVentiOn (NCT04809246) · Clinical Trials Directory